Taxane chemotherapy is unable to sensitize prostate cancer to immune checkpoint inhibitors, resulting in another negative trial with immunotherapy in prostate cancer,” said Andrea Necchi, MD.

A high level of activity was found with docetaxel administered as a single agent every 3–4 weeks in elderly patients with advanced breast cancer. The use of prophylactic measures, including ...

All medicines have risks and benefits. Your doctor has weighed the risks of you taking DBL Docetaxel, Concentrated Injection against the benefits they expect it will have for you. If you have any ...

Furthermore, docetaxel (the drug of choice for the first-line treatment of castration-resistant PC) cannot cross the blood–brain barrier and control metastatic foci. However, this problem may be ...

Prostate cancer is one of the most common types of cancer in men. Docetaxel (DTX) has been chosen for this project as it is the standard of care for prostate cancer and has been injected bi-weekly ...

According to Novocure, the Optune Lua system is now approved for use in combination with PD-1/PD-L1 inhibitors or docetaxel ...

Assessment of cardiovascular (CV) toxicity by providers in advanced prostate cancer (PCa) patients (pts) on novel hormonal therapy (NHT). This is an ASCO Meeting Abstract from the 2025 ASCO ...